Related Experiment Videos
[Multiple myeloma: epidemiologic and clinical considerations].
P Pasqualetti1, A Collacciani, D Colantonio
1Dipartimento di Medicina Interna, Università degli Studi de L'Aquila.
Giornale Italiano Di Oncologia
|July 1, 1990
Summary
This study analyzed 184 multiple myeloma cases from 1970-1989. Findings show higher incidence in males over 65, with bone pain and anemia as key symptoms, and renal failure as a major cause of death.
Area of Science:
- Oncology
- Epidemiology
- Clinical Medicine
Context:
- Multiple myeloma is a cancer of plasma cells.
- Understanding epidemiological trends and clinical features is crucial for patient management.
- This study examines a cohort diagnosed between 1970 and 1989.
Purpose:
- To report epidemiological and clinical considerations for multiple myeloma.
- To analyze incidence rates, patient demographics, and presenting symptoms.
- To evaluate survival outcomes and the impact of the Durie and Salmon staging system.
Summary:
- The mean annual incidence rate was 5.1 per 100,000, with higher prevalence in males and individuals over 65.
- Bone pain and anemia were the most common presenting symptoms; renal failure was the leading cause of death.
- Three-year survival was approximately 60%, and five-year survival was around 45%, with significant differences observed across Durie and Salmon staging groups.
Impact:
- Provides insights into historical multiple myeloma trends and risk factors.
- Highlights the importance of early symptom recognition and management of renal complications.
- Demonstrates the prognostic value of the Durie and Salmon staging system in multiple myeloma.